The Forward P/E of Antisense Therapeutics Ltd (ANP.AX) is N/A.
Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.
| Ticker | Name | Value |
|---|---|---|
| IDT.AX | IDT Australia Ltd | 6.22 |
| NEU.AX | Neuren Pharmaceuticals Ltd | 43.74 |
| ACR.AX | Acrux Ltd | 0.30 |